Page last updated: 2024-10-27

fleroxacin and Infections, Klebsiella

fleroxacin has been researched along with Infections, Klebsiella in 1 studies

Fleroxacin: A broad-spectrum antimicrobial fluoroquinolone. The drug strongly inhibits the DNA-supercoiling activity of DNA GYRASE.
fleroxacin : A fluoroquinolone antibiotic that is 4-oxo-1,4-dihydroquinoline which is substituted at positions 1, 3, 6, 7 and 8 by 2-fluoroethyl, carboxy, fluoro, 4-methylpiperazin-1-yl and fluoro groups, respectively. It is active against many Gram-positive and Gram-negative bacteria.

Research Excerpts

ExcerptRelevanceReference
"Fleroxacin is a newly developed quinolone derivative with marked antimicrobial activity."1.27Therapeutic effect of fleroxacin against experimental pneumonia in mice. ( Niki, Y; Soejima, R; Tasaka, Y; Umeki, S; Watanabe, M, 1988)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Niki, Y1
Watanabe, M1
Tasaka, Y1
Umeki, S1
Soejima, R1

Other Studies

1 other study available for fleroxacin and Infections, Klebsiella

ArticleYear
Therapeutic effect of fleroxacin against experimental pneumonia in mice.
    The Journal of antimicrobial chemotherapy, 1988, Volume: 22 Suppl D

    Topics: Animals; Anti-Infective Agents; Cefaclor; Ciprofloxacin; Fleroxacin; Klebsiella Infections; Klebsiel

1988